News XOMA Royalty Corporation Nasdaq

Equities

XOMAP

US98419J3059

Market Closed - Nasdaq Other stock markets 02:00:01 16/07/2024 am IST			5-day change	1st Jan Change
25.5 ^USD	-1.54%		-0.09%	+0.35%

10/07	XOMA Corporation will Change its Name to XOMA Royalty Corporation	CI
09/07	Xoma Changes Name to Xoma Royalty	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

XOMA Corporation will Change its Name to XOMA Royalty Corporation	10/07	CI
Xoma Changes Name to Xoma Royalty	09/07	MT
XOMA Corporation(NasdaqGM:XOMA) added to Russell 3000 Growth Index	01/07	CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell Microcap Growth Index	01/07	CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell 3000E Growth Index	01/07	CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell 2000 Growth Index	01/07	CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell 2500 Growth Index	01/07	CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell Small Cap Comp Growth Index	01/07	CI
XOMA Declares Quarterly Preferred Stock Dividends	20/06	AQ
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals Sale of its Priority Review Voucher	13/06	AQ
XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher	12/06	MT
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher	12/06	AQ
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ	14/05	AQ
Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M	09/05	MT
Xoma: Q1 Earnings Snapshot	09/05	AQ
Tranche Update on XOMA Royalty Corporation's Equity Buyback Plan announced on January 2, 2024.	09/05	CI
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities	09/05	AQ
XOMA : 2024 Letter to Shareholders	09/05	PU
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	30/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News XOMA Royalty Corporation Nasdaq

Equities

XOMAP

US98419J3059

Summary

Filters